Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ECO, CSR, SRI

CHUM Foundation receives landmark $15 million donation from Quebecor


The biggest donation in Foundation history 

MONTRÉAL, Feb. 13, 2018 /CNW Telbec/ - It is with great emotion and pride that Quebecor today makes a $15 million donation to the Fondation du centre Hospitalier de l'Université de Montreal (CHUM), as part of the Foundation's "Donnons-nous le meilleur de la santé" (Giving ourselves the best in healthcare) capital fundraising campaign. The landmark donation is the largest philanthropic commitment made since the Foundation was created in 1998.

Logo: Fondation du CHUM, Quebecor (CNW Group/Fondation du CHUM)

"As a company we have a responsibility to act in solidarity with our community," stated Quebecor CEO and President Pierre Karl Péladeau. "At Quebecor, we haven't forgotten the commitment made by my father, Pierre Péladeau, which is why we're proud to make this $15 million donation to the CHUM Foundation. Our contribution will help this major hospital centre pursue its mission of excellence while continuing to provide the best possible care. This is a vital legacy for future generations, and our way of carrying on my father's philanthropic work."

In recognition of the donation, the CHUM will pay tribute to the visionary Québec businessman by naming its amphitheatre, the architectural centrepiece of the new hospital's third and final phase, after Pierre Péladeau.

"Giving ourselves the best in healthcare"
Former Québec premier Daniel Johnson, Chairman of the Campaign Cabinet, thanked Quebecor for their generosity and highlighted their invaluable contribution. Johnson emphasized the company's role as a leading ally in this project, which will leave a lasting mark on Québec's healthcare system and society as a whole. "Thanks to the support of leaders like Quebecor, the new CHUM will have a society-wide impact while achieving the highest standards of excellence. Today we're celebrating the power of collaboration: two leaders in their respective fields standing as one to give Quebecers the very best in healthcare. I'm sincerely thankful for this donation, which will go down in history as the largest the Foundation has received to date."

With the support of committed partners like Quebecor, CHUM can fulfill its mission of achieving excellence in patient care, research and teaching, to better cure diseases and improve the health of Quebecers. The Foundation's capital fundraising campaign, one of the Canadian healthcare sector's largest, will foster growth and enhance the CHUM's performance through the acquisition of state-of-the-art equipment and support for research, teaching, health promotion and patient experience initiatives. Thanks to its generous donors, the campaign has reached 75% of its $300 million objective. 

In the words of President and CEO of CHUM and CHU Sainte-Justine, Dr. Fabrice Brunet: "Quebecor is making an impressive contribution to the health of the Québec population, which comes at a turning point for the CHUM. Our teams have already begun providing quality care in our new leading-edge facilities, and we're embarking on the last phase of its construction. This final stage includes the project's centrepiece, the amphitheatre, which will be a welcoming, state-of-the-art facility that will foster innovation, health promotion and knowledge sharing throughout Québec's healthcare system and the world."   

The grand opening of the CHUM's Amphithéâtre Pierre-Péladeau is slated for 2021.

About Quebecor
Quebecor, a Canadian leader in telecommunications, entertainment, news media and culture, is one of the best-performing integrated communications companies in the industry. Driven by their determination to deliver the best possible customer experience, all of Quebecor's subsidiaries and brands are differentiated by their high-quality, multiplatform, convergent products and services.

Quebecor (TSX: QBR.A, QBR.B) is headquartered in Québec. It holds an 81.53% interest in Quebecor Media, which employs more than 10,000 people in Canada. A family business founded in 1950, Quebecor is strongly committed to the community. Every year, it actively supports people working with more than 400 organizations in the vital fields of culture, health, education, the environment and entrepreneurship.

Visit our website: www.quebecor.com 
Follow us on Twitter: twitter.com/Quebecor

About the Fondation du CHUM
The Fondation's mission is to provide a complementary source of funding for the CHUM. The support of a foundation is required in order for a healthcare institution to have the capacity to expand its local, national and international reputation and influence, and to accelerate its technological developments. The Fondation du CHUM serves as a catalyst and a driving force in carrying out the CHUM's mission, with its numerous initiatives, its fundraising activities, and its capital fundraising campaign.

 

SOURCE Fondation du CHUM


These press releases may also interest you

at 02:30
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 02:10
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative drugs for the treatment of rare genetic diseases, utilizing its proprietary CRISPR-based epigenome editing technology CRISPR-GNDM®, posted the...

at 02:00
Exams can be daunting for students and parents, but with the right approach it can become a rewarding and manageable experience. Expert private tutors can support academic study and exam-readiness while promoting students' mental health with...

at 02:00
As part of its Global Science Summit, the Novo Nordisk Foundation issues an international open call for research projects to catalyse science-based solutions to key global challenges. The programme expects to hand out up to eight grants with a total...

at 02:00
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its...

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...



News published on and distributed by: